#Global Assisted Reproductive Technology Market

[janetushar1]

Assisted Reproductive Technology Market to Hit $40.9 Billion by 2032

The global Assisted Reproductive Technology Market was valued at USD 25.1 Billion in 2024 and it is estimated to garner USD 40.9 Billion by 2032 with a registered CAGR of 6.3% during the forecast period 2024 to 2032.

Global Assisted Reproductive Technology Market Research Report 2024, Growth Rate, Market Segmentation, Assisted Reproductive Technology Market. It affords qualitative and quantitative insights in phrases of market size, destiny trends, and nearby outlook Assisted Reproductive Technology Market. Contemporary possibilities projected to influence the destiny capability of the market are analyzed in the report. Additionally, the document affords special insights into the opposition in particular industries and diverse businesses. This document in addition examines and evaluates the contemporary outlook for the ever-evolving commercial enterprise area and the prevailing and future outcomes of the market.

Get Sample Copy of Report @ https://www.vantagemarketresearch.com/assisted-reproductive-technology-market-2403/request-sample

** Note: You Must Use A Corporate Email Address OR Business Details.

The Major Players Profiled in the Market Report are:-

Thermo Fisher Scientific Inc. (U.S.), Oxford Gene Technology IP Ltd. (UK), Genea Biomedx (Australia), The Cooper Companies Inc. (U.S.), Inception Sciences Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Vitrolife AB (Sweden)

Assisted Reproductive Technology Market 2024 covers powerful research on global industry size, share, and growth which will allow clients to view possible requirements and forecasts. Opportunities and drivers are assembled after in-depth research by the expertise of the construction robot market. The Assisted Reproductive Technology Market report provides an analysis of future development strategies, key players, competitive potential, and key challenges in the industry.

Global Assisted Reproductive Technology Market Report 2024 reveals all critical factors related to diverse boom factors inclusive of contemporary trends and traits withinside the worldwide enterprise. It affords a complete review of the top manufacturers, present-day enterprise status, boom sectors, and commercial enterprise improvement plans for the destiny scope.

The Assisted Reproductive Technology Market document objectives to offer nearby improvement to the market using elements inclusive of income revenue, destiny market boom rate. It gives special observation and analysis of key aspects with quite a few studies strategies consisting of frenzy and pestle evaluation, highlighting present-day market conditions. to be. Additionally, the document affords insightful records approximately the destiny techniques and opportunities of worldwide players.

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/assisted-reproductive-technology-market-2403/0

Global Assisted Reproductive Technology Market, By Region

1) North America- (United States, Canada, Mexico, Cuba, Guatemala, Panama, Barbados, and many others)

2) Europe- (Germany, France, UK, Italy, Russia, Spain, Netherlands, Switzerland, Belgium, and many others)

3) the Asia Pacific- (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Vietnam, and many others)

4) the Middle East & Africa- (Turkey, Saudi Arabia, United Arab Emirates, South Africa, Israel, Egypt, Nigeria, and many others)

5) Latin America- (Brazil, Argentina, Colombia, Chile, Peru, and many others)

This Assisted Reproductive Technology Market Research/analysis Report Contains Answers to your following Questions

What trends, challenges, and barriers will impact the development and sizing of the global market?

What is the Assisted Reproductive Technology Market growth accelerator during the forecast period?

SWOT Analysis of key players along with its profile and Porter’s five forces analysis to supplement the same.

How much is the Assisted Reproductive Technology Market industry worth in 2019? and estimated size by 2024?

How large is the Assisted Reproductive Technology Market? How long will it keep growing and at what rate?

Which section or location will force the market and why?

What is the important thing current tendencies witnessed in the Assisted Reproductive Technology Market?

Who are the top players in the market?

What and How many patents are filed by the leading players?

What is our Offering for a bright industry future?

The Research Objectives of this Report are to:-

Company, key regions/countries, merchandise and applications, historical records from 2018 to 2022, and global Assisted Reproductive Technology Market till 2032. Study and analyze the market length (cost and volume).

To recognize the structure of Assisted Reproductive Technology Market via way of means of figuring out its numerous subsegments.

Assisted Reproductive Technology Market on the subject of the primary regions (with every essential country). Predict the cost and length of submarkets.

To examine the Assisted Reproductive Technology Markets with appreciation to person boom trends, destiny prospects, and their contribution to the general market.

To examine aggressive trends consisting of expansions, contracts, new product launches, and acquisitions withinside the market.

Strategic profiling of key gamers and complete evaluation of growth strategies.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/assisted-reproductive-technology-market-2403

Reasons to Buy Market Report

The market record presents a qualitative and quantitative analysis of the market based on segmentation that includes each economic and non-economic element.

Assisted Reproductive Technology Market through the region. The market evaluation highlights the consumption of products/services in areas and well-known shows elements influencing the market in every region.

Assisted Reproductive Technology Market. It consists of an in-depth analysis of the market from specific views via Market Porter's Five Forces Analysis and provides insights into the market via the Value Chain.

The Assisted Reproductive Technology Market file provides an outline of market fee (USD) information for every segment and sub-segment.

It consists of an in-depth analysis of the market from distinct views via a 5 forces analysis of the Assisted Reproductive Technology Market and offers insights into the market through the fee chain.

Check Out More Reports

Global Pet Insurance Market :  Report Forecast by 2032

Global Electric Powertrain Market: Report Forecast by 2032

Global AI in Video Surveillance Camera Market: Report Forecast by 2032

Global Auto Repair Software Market: Report Forecast by 2032

Global Electronic Bill Presentment and Payment Market: Report Forecast by 2032

[probablyasocialecologist]

The World Food Summit of 1996 approached food security through the principles of ensuring there is enough safe and nutritious food that can be accessed daily to meet healthy dietary needs and food preferences. By definition, this is a desirable and worthy goal. However, in the years since, food security has developed into a paradigm which does not question the underlying power dynamics and the reproduction of material conditions that make food insecurity a permanent feature of the global order. At its core, the food security paradigm deals only with access to food, without challenging the political and economic structures that determine and control access, as well as distribution.  By failing to address the root causes of hunger and famine, the food security paradigm makes it impossible to end hunger globally. Of course, many people worldwide possess food security, but this is restricted to increasingly limited geographic pockets. In terms of the people localised in one area, food vulnerability is influenced and determined by class, race, gender and, of course, citizenship status. Globally, “underdevelopment” and “de-development” lead to widespread food insecurity across areas. Another problem with the food security paradigm is that it is easily co-opted to generate partial answers that pose no threat to the corporate food system, or worse, that even open up new profit opportunities. Accelerated by other crises, the food security paradigm becomes ever more dependent on aid, be it through direct food delivery, cash transfers or small development projects that cannot compete with the food giants and their price-setting powers. In practice, a “science of food security” emerges, one which takes as its focus calories and the output that is compatible with precision agriculture having the aim to increase crop yields and to assist management decisions using high technology sensor and analysis tools. This model tends to be reliant on “Green Revolution” technologies that rely on chemical fertilisers and pesticides and that are tied to colonial projects and corporations, in order to optimise resources in aid response and/or development projects.  In this rationale, food insecurity can be addressed by reaching optimum yields of certain crops that should meet the demand for fats, fibres and protein. All of this is carefully managed and data-driven. Precision farming is advocated by the Alliance for a Green Revolution in Africa (AGRA) with the objective of optimising, “agricultural value chains […] critical in advancing food and nutrition sufficiency without increasing the size of land under cultivation.” The framing of food that reduces it only to “optimal input” relegates vital elements of food production and the culture of eating, like territory ownership, taste, heritage, care, well-being and connection as secondary. This reductionist approach has, though, proved useful to corporate agriculture, since it reinforces the case for genetically modified crops (GMOs), more efficient fertilisers, and the standardisation of food production for market purposes. Advocates of plant breeding technologies (including GMOs and hybrid seeds) argue that government overregulation is an obstacle to achieving food security. Overregulation, as the argument goes, denies populations the opportunity to grow crops that have increased nutrient use efficiency and are more resilient to climate shocks. 

[...]

The paradigm of food security is about optimising productivity. It’s true that productivity matters – after all, feeding the world requires enormous quantities of food. But if productivity is approached solely as a technological problem, it reinforces the tendency to fragment the quantitative and qualitative aspects of food production and consumption. On the quantitative side, production for food security is viewed as a challenge of multiplication. Whereas division, that is, distribution of food, is left to logistical planning. This ignores what Raj Patel identified in his influential 2007 book Stuffed and Starved, as the bottleneck of power that concentrates international food distribution among a small set of corporations. This bottleneck excludes the poor and small-scale food producers from decision-making. It also normalises worrying tendencies, such as an overreliance on industrial animal exploitation as a protein source, which has direct health implications, as well as longer term consequences like the proliferation of new viruses, greenhouse gas emissions and inefficient use of water and soil.

28 May 2024

[coochiequeens]

Can there be an ethical way to exploit a woman for a womb and treat a baby like a commodity?

The global surrogacy industry is experiencing an unprecedented boom, raising ethical concerns across borders. As more couples turn to surrogacy as a path to parenthood, this assisted reproductive technology has evolved into a multi-billion dollar market.

According to recent research, the global surrogacy industry is projected to grow from $21.85 billion in 2024, to $196 billion by 2034. This explosive growth is primarily concentrated in Europe and North America, where surrogacy is legal and regulated. 

However, the legal landscape of surrogacy remains a complex patchwork across nations, with some countries embracing it while others maintain strict prohibitions. This inconsistency in regulations has created gray areas.

Scientific research highlights the possibility of abuse arising from gaps in legal frameworks and disputes, whether surrogacy is legal or not. It points to unethical practices such as trafficking of women, coercion of both surrogates and prospective parents by agencies, lack of respect for bodily autonomy or informed consent, ‘sham’ procedures and multiple embryo exchanges.

Cross-Border Exploitation: A Dark Web of Surrogacy

Surrogacy-related abuse often happens in a region formed by three countries: Turkey, Georgia and Northern Cyprus.

While surrogacy remains illegal in Turkey, it’s perfectly legal in its northeastern neighbor Georgia and southern neighbor Northern Cyprus, creating a dangerous legal vacuum that enables exploitation.

The Hope for the Future Association, based in Tbilisi, Georgia, is one of the organizations reporting cases of abuse and illegal surrogacy in the country. 

“Our organization has evidence of both Georgian and Turkish citizens being used as surrogate mothers, along with cases of children being transported across borders with falsified documents,” said Tamar Khachapuridze, the association’s director. “We’ve reported these to the prosecutor’s office. Despite a decade-long investigation by Georgian prosecutors, these cases remain collecting dust. It appears someone is working to keep these dark dealings under wraps.” 

While surrogacy remains illegal in Turkey, it’s perfectly legal in its northeastern neighbor Georgia and southern neighbor Northern Cyprus, creating a dangerous legal vacuum that enables exploitation.

The Hope for the Future Association, based in Tbilisi, Georgia, is one of the organizations reporting cases of abuse and illegal surrogacy in the country. 

“Our organization has evidence of both Georgian and Turkish citizens being used as surrogate mothers, along with cases of children being transported across borders with falsified documents,” said Tamar Khachapuridze, the association’s director. “We’ve reported these to the prosecutor’s office. Despite a decade-long investigation by Georgian prosecutors, these cases remain collecting dust. It appears someone is working to keep these dark dealings under wraps.” 

Khachapuridze cited a particularly alarming case involving a Turkish surrogate mother. After undergoing embryo transfer in Georgia, she was reportedly transported to Thailand three months before giving birth, where she delivered a baby intended for a single Chinese man.

This case directly violates Georgian law, which explicitly prohibits embryo transfer or any surrogacy procedures for women from foreign countries.

When we obtained the case number from Khachapuridze’s files and approached the Georgian Prosecutor’s Office with written questions about the existence and content of the investigation, our written inquiries and follow-up calls went unanswered.

Rusudan Nanava, a Tbilisi-based lawyer handling surrogacy cases, explained the wall of silence: “I doubt you’ll get any information from the prosecutor’s office. Criminal cases, especially those involving surrogacy, are treated with the highest level of confidentiality.”

Georgia’s Legislative Tug of War: Balancing Ethics and Economics

In a significant policy shift, the Georgian government is grappling with proposed legislation that could fundamentally reshape the country’s surrogacy landscape. The move comes amid growing concerns over human trafficking and exploitation in the industry.

“We’re seeing cases of law abuse, including human trafficking,” said independent member of parliament  Tamar Kordzaia. “While the government pushes for change through surrogacy laws, I believe we could address these issues through other regulatory measures.”

The controversial bill, introduced in June 2023, would effectively end commercial surrogacy in Georgia, permitting only altruistic arrangements. This shift would bar foreign couples—who currently make up 95 percent of intended parents—from accessing Georgian surrogacy services, restricting the practice to Georgian citizens only.

However, Kordzaia remains skeptical about the bill’s future, which has yet to take effect.  

“This is moving at a glacial pace, despite the government’s ability to fast-track legislation when it wants to,” she said. “The economic implications are severe—both for medical facilities and the women who rely on surrogacy income. I suspect the bill will ultimately be withdrawn.”

In a country where 11.5 percent of women aged 18-65 live below the absolute poverty line, surrogacy has become a lifeline for many Georgian women struggling to make ends meet. Their stories paint a stark picture of economic desperation intersecting with the global fertility market.

Take Teona, a 42-year-old teacher and domestic violence survivor, who turned to surrogacy twice a decade ago. “As a woman, I wanted to help another woman who couldn’t have children,” she said, her voice tinged with both pride and pragmatism. “Of course, there was financial motivation. My main goal was to buy my own apartment, and I did it—for my child’s future.”

Dr. Keti Gotsiridze, director of the Reproductive Health Center of the Chachava clinic, one of Georgia’s well-established health institutions, said according to the data research of her clinic, surrogacy practice contributes $300 million a year to health tourism. Gotsiridze said 90 percent of their clients are foreigners. Surrogate mothers are paid 25-30 thousand Euros; Chachava works with an average of 300-400 surrogate mothers a year. 

For the time being, it seems that the new legislation to change the practice of surrogacy in Georgia has been shelved due to economic concerns. However, the question of how to prevent human trafficking, which has also emerged with the abuse of the existing law, remains unanswered. 

Cross-Border Surrogacy Investigation Closes With No Charges Filed

A prosecutorial investigation has revealed an alleged surrogacy trafficking network spanning Turkey, Georgia and Northern Cyprus, highlighting the devastating human cost of unregulated fertility treatments.

The case began on Sept. 3, 2021, when Turkey’s Health Ministry received an anonymous tip about “F. IVF (In Vitro Fertilization) Center,” a fertility clinic in Istanbul’s affluent Beşiktaş district. According to the whistleblower, the clinic was targeting vulnerable young women, including minors, from the working-class neighborhood of Ümraniye with promises of financial gain through surrogacy.

The scheme was elaborate: Women were provided with fertility drugs to use at home for durations  ranging from two to 12 days. They were then allegedly trafficked to Georgia and Northern Cyprus using forged documents, with all expenses covered by the network. The fertility medications were reportedly sourced from pharmaceutical warehouses and distributed through a café in Üsküdar, serving as a front for the operation.

Despite the gravity of these allegations, the investigation faced significant hurdles. After a year-long probe, authorities could only identify one suspect, known as A.A., who allegedly recruited the women. The café implicated in the scheme closed its doors just one month before police surveillance began.

When we reached out to M.K., the lawyer who owned the café, he confirmed his ownership but denied any knowledge of the fertility drug distribution, claiming he was also a victim in the scheme.

Another crucial lead emerged regarding Dr. S.T., who allegedly treated the women at “F. IVF (In Vitro Fertilization) Center” and later deleted their medical records. However, police terminated the investigation, citing lack of evidence and the doctor’s clean criminal record.

When reached for comment, Dr. S.T. denied all allegations, dismissing the claims made in the investigation as baseless.

The case took another turn when the Istanbul Public Prosecutor’s Office dismissed the case in January 2023. The Provincial Health Directorate appealed, arguing that “the investigation was inadequate” and “the material and moral elements of the crime have not been fully established.” Nevertheless, on May 31, 2023, the Istanbul 7th Criminal Court of Peace rejected the appeal without explanation.

The case remains closed, leaving crucial questions unanswered about the fate of these young Turkish women, the conditions they endured, and the clinics involved in Georgia and Northern Cyprus. The Ministry of Health has remained silent on queries about similar reported cases, raising concerns about the scale of this cross-border surrogacy trade. 

A Cross-Border Underground Surrogacy Network

A police raid in Istanbul in 2019 exposed a sophisticated trafficking network spanning Turkey, Georgia and Northern Cyprus. The operation revealed a complex web involving a Northern Cypriot ringleader and two Moldovan accomplices who coordinated the trafficking of Turkish women for surrogacy purposes.

During the raid, police discovered large quantities of fertility drugs. According to detained suspects’ testimonies, these hormones were supplied by the Northern Cypriot kingpin and administered to potential surrogate mothers recruited from Turkey. The women were then trafficked to clinics in both Northern Cyprus and Georgia, with one prominent facility identified as “IVF Tours Georgia” in Tbilisi.

To verify whether this clinic continues to engage with Turkish women five years after the raid, we conducted an undercover investigation. Posing as potential surrogates from Turkey, we contacted “IVF Tours Georgia” via email. The response was swift and telling: Not only did they accept our inquiry, but they immediately began discussing financial arrangements and medical screenings. This exchange revealed a striking fact: Despite Georgian law restricting surrogacy to Georgian citizens, the clinic openly offered services to Turkish nationals, highlighting the persistent nature of this illegal cross-border trade.

Lack of Oversight Fuels Surrogacy Concerns in Northern Cyprus

In Northern Cyprus, a growing surrogacy industry operates within a complex web of legal ambiguity and insufficient oversight, despite having well-crafted regulations. Former health minister (2018-2019) and Republican Turkish Party MP Filiz Besim warns that human trafficking cases persist due to inadequate supervision.

“While we have meticulously drafted laws permitting surrogacy, the lack of oversight remains a critical issue,” Besim said. “Our unique position outside international law, due to our unrecognized status, has created vulnerabilities that are being extensively exploited. This has led to the emergence of illicit international networks involved in human, women, and child trafficking.”

Deputy Besim emphasizes that women—particularly from Caucasian countries—are being brought from abroad as surrogate mothers in violation of laws. He notes that due to insufficient oversight, questions remain about the agreements, facilitators, and conditions under which these women are transported.

Our anonymous field interviews and observations reveal serious concerns about surrogacy practices stemming from the country’s lack of oversight. A troubling gray area has emerged where low-income women face potential exploitation. Women may be pressured into surrogacy due to financial hardship, raising ethical concerns about the commodification of women’s bodies and children’s rights.

International organizations like U.N. Women have voiced similar concerns about surrogacy practices in regions like Northern Cyprus, citing these risks and inadequate oversight. They stress the importance of protecting surrogate mothers through proper safeguards: ensuring they are fully informed, free from coercion, and fairly compensated for the risks they undertake

Surrogacy became legal in Northern Cyprus in August 2016 under the Law Regulating Human Cell, Tissue, and Organ Transplantation Rules. A new, more robust bill was drafted in April 2023, though Parliament has yet to convene to discuss these changes.

Northern Cyprus has emerged as Europe’s leading destination for reproductive treatments. The industry’s prominence is evident in everyday encounters in the capital, Lefkoşa, where stories of successful surrogacy arrangements—including a recent case involving a European couple—are commonplace.

While official statistics remain undisclosed, artificial intelligence analysis estimates approximately 500 surrogacy arrangements occur annually in Northern Cyprus. According to LaingBuisson, a London-based healthcare market research firm, the country handles about 11 percent of all egg donation treatments in Europe.

Social Media’s Underground Surrogacy Market

Despite legal bans and restrictions, a thriving underground surrogacy market in Turkey continues to operate in plain sight. There are numerous advertisements openly seeking surrogate mothers on social media platforms such as Instagram and Facebook. 

In one of these advertisements, we wrote  to a woman who said  she could  be a surrogate mother, with a request to have a child. Ten years ago in Turkey, the woman said she had been a surrogate mother once and explained how the process would work and offered us two methods to help her conceive:

“The child could be from my egg and your husband’s sperm. Would you be okay with that after birth? We’d never need to know each other. We wouldn’t even need a transfer. We could handle it ourselves – inject your husband’s sperm directly into my uterus. Or, we could select healthy eggs and have your and your husband’s eggs transferred to me.”

Most alarmingly, she assured us that certain private clinics would perform these procedures clandestinely, promising there would be “no issues” with birth certificates—a clear indication of document fraud.

The desperation of infertile couples seeking parenthood through these illegal channels may be understandable, but the risks are severe. These back-alley procedures not only endanger the health of all parties involved but also expose them to serious legal consequences. The combination of medical risks and criminal liability creates a potential storm of challenges for vulnerable individuals. 

The Delicate Balance: Finding a Legal Middle Ground

Is there a way to craft ideal legislation that prevents exploitation while acknowledging the deep human desire for parenthood? Attorney and professor Dr. Özlem Yenerer Çakmut believes the answer lies in nuanced regulation rather than absolute prohibition.

“We can’t simply ignore the profound yearning of those who dream of experiencing not just parenthood, but the entire journey—from pregnancy to birth,” Yenerer explained. “These are couples who want more than adoption; they want to be part of every moment, every milestone.”

“The challenge lies in striking a delicate balance between regulation and prohibition,” she continued. “A blanket ban isn’t the answer, especially in societies where having children carries immense social and cultural weight. While we can’t legitimize illegal practices, we can work toward meaningful legislation that protects all parties involved while acknowledging these deeply human desires.”

There is also a section of the world strongly opposed to surrogacy. At its forefront stands the Casablanca Declaration, a document signed by 100 experts from 75 countries in March 2023, calling for a universal ban on surrogacy practices.

Leading this charge is Olivia Maurel, herself born through surrogacy in 1991, who has emerged as one of the movement’s most compelling voices. 

“Standing against surrogacy means advocating for its universal abolition,” Maurel declared with conviction born of personal experience. “This isn’t just about abstract principles—it’s about defending the fundamental rights of women and children, about protecting human dignity in its most basic form. Surrogacy, by its very nature, undermines these essential values.”

For some, surrogacy represents a last resort in their journey to parenthood. A 46-year-old woman living in Georgia, who chose to remain anonymous, shared the challenging aspects of this process. After having her uterus and ovaries removed due to health issues, she and her husband decided to pursue surrogacy six years ago.

The woman described maintaining close contact with the surrogate mother both before the transfer and throughout the pregnancy. “I monitored her doctor visits, tests and medications regularly. I ensured she maintained a healthy diet, and I was present during the birth. I was with my baby from the moment of delivery.”

Despite being a challenging and costly process, she pursued surrogacy to fulfill her dream of motherhood. “If surrogacy is the only path to becoming a mother, you must give it your all, learn to manage your emotions, and stay focused on your goal. The difficulties and pain are temporary; the love for a child is permanent,” she said.

E.U. Redefines Surrogacy Regulations

Recent legal scholarship challenges the traditional binary approach of outright bans versus complete legalization. Instead, experts advocate for a nuanced international framework that transcends cultural and moral absolutes while protecting fundamental human rights. This perspective emphasizes the critical need for comprehensive national legislation in countries where surrogacy exists, whether legal or not, to safeguard the rights of both women and children.

Amid this contentious landscape, the European Parliament Council took decisive action on Jan. 23, 2024, reaching a provisional agreement to classify exploitative surrogacy practices as human trafficking. The measure was formally adopted on May 27, 2024.

The new framework imposes strict penalties on those who exploit women through forced surrogacy or deceptive practices, while establishing comprehensive support systems for victims. E.U. member states must implement these protections into their national legislation within two years.

The production of this investigation is supported by a grant from the IJ4EU fund. The International Press Institute (IPI), the European Journalism Centre (EJC) and any other partners in the lJ4EU fund are not responsible for the content published and any use made out of it.

This reporting was supported by the International Women’s Media Foundation’s Howard G. Buffett Fund for Women Journalist

About Seda Karatabanoğlu and Zeynep Yüncüler

Seda Karatabanoğlu graduated with a bachelor's degree from Istanbul University's Faculty of Communication in Turkey and a master's degree in European studies and international relations at l'Université Paul-Valéry in France. She worked at Cumhuriyet Newspaper. Her articles have been published on many online platforms such as Euronews Turkish and DW Turkish. Currently residing in France, she continues her work as an independent journalist.

Zeynep Yüncüler is a graduate of Izmir University of Economics, where she studied in the Media and Communication Department. She worked at Milliyet Daily, 'Artı 1' TV, BirGün Daily, ‘Artı Tv’ and Punto24, an independent journalism platform in Turkey. She also served as the secretary for the Journalists’ Union of Turkey's Istanbul branch. She was honored with the best interview award (2016) by the Progressive Journalists’ Association (ÇGD). Currently, she is a freelancer.

[theblissfulstars]

New Moon in Aries March 21st, 11'23AM EST

The new moon happening on March 21st at 11:23 EST is definitely a doozy, and setting the stage for the final moments of the big transition before Pluto enters Aquarius and Mars enters Cancer.

This new moon is initiating the astrological new year as the sun is entering Aries. With the new moon occurring on the zodiac sign of Aries, there are definitely a lot of martian themes in this new moon. This is all about revolution, dynamism, explosivity and change taking place on a global scale. These are going to be changes largely regarding structures and hierarchies in patriarchy and other masculine dominated ideologies. This is the time of conflict, battle, and a new cycle of war being initiated. The MC for this new moon is in the zodiac sign of Aries, denoting a time of massive pivotal change, particularly regarding power dynamics that we've been wrestling with as a collective. This sun and moon are square transiting Mars in Gemini by degree orb denoting that this is going to be a time of dominance being asserted over the people collectively through information. Be very cognizant of the information that you were absorbing during this time as it is being utilized to control you and your energy, keep hope, keep faith and stay organized and mobile. Pluto is sextile the sun and moon, creating opportunities for transformations around power dynamics that assists the collective.

With Mercury at 5° in Aries, the number five numerologically resonates with change, motion and movement. With Mercury here who rules the number five, there are a lot of changes to our thoughts, thinking habits and modes of communication. There could be a major change in how we communicate from this new moon, for instance, new communication technologies being introduced or destroyed. With Chiron conjunct Jupiter and Vesta, there is a massive healing going on collectively surrounding ideologies and philosophies about masculinity, war and domination and how we're going to be healing that. Are we going to continue to allow this loop to continue or are we going to break it? With all of this happening in the 10th house, we can expect government, policy and hierarchical structures to play a major part in this new moon. Are we building a future we want or fear?

Venus in her dignity is at 5 degrees, conjunct Juno at 5. This here speaks to a fortuitous and wonderful time to find romantic, long-term love and romance. This is also an excellent time to look for business partnerships as well as consolidate and make things official in connections. There is a very heavy financial theme to this new moon, and the corporate space is going to be making major moves in how we handle our values, particularly around the environment, beauty and pleasure. This is a wonderful time for us to get our finances in check, and maybe even get some spiritual financial blessings. Venus is square Pluto, showing that the collective is going through a transformation of our values, particularly how power structures negatively affects our money and ability to have pleasure. The stock market is going through instability. Venus is sextile Saturn showing that there's an opportunity to stabilize if we use our minds and souls wisdom as a collective. With all of this taking place in the 11th house, get out there and socialize! This means it is going to be encouraging us to step outside of our houses. Make those connections, and at the risk of being crass, making those physical connections.

With Mars in the 12th, be aware of dreams this new moon and be safe in the astral. Don't let past trauma run the show, as unsublimated anxiety can break you down.

With a cancer ascendant capping this new moon with Pallas athene in cancer square Jupiter and Chiron in Aries, this speaks to a time of justice surrounding local politicians, figures of nationalism, and figures who are oppositional to feminine rights. We can expect issues around reproductive rights to arise.

Workings:

New beginnings

Money

Love

Seggs

Destruction

Revolution

Justice

[i-nilesh-blog]

Decoding the Biological Clock: Analyzing the Fertility Testing Market

The fertility testing market is expanding at a tremendous rate, driven by shifting social trends, improving diagnostic technologies, and increasing knowledge about reproductive health. With couples delaying childbearing and infertility rates on the rise, the demand for cost-effective and trustworthy fertility testing solutions is increasing leaps and bounds.

This market is driven by a number of major factors. First, the increasing incidence of infertility, due to causes such as age, lifestyle, and disease, is creating demand for testing products. Second, improvements in assisted reproductive technologies (ART) have heightened demand for accurate fertility testing. Third, access to home fertility testing kits and digital health options is increasing access to testing and enabling individuals to take control of reproductive health.

Market study indicates a strong growth path. The global market for fertility tests is expected to grow to very large numbers with a high CAGR. Rising healthcare spending, increasing education on reproductive health, and the growing adoption rate of high-tech diagnostic platforms are driving this growth. The market is segmented by type of test (ovulation test, sperm test, ovarian reserve test, hormone test), end-user (home care, clinics, hospitals), and geography. Growth trends and intricacies vary between each segment.

Increased consumption of in-home fertility test kits is a leading trend. The kits are affordable, confidential, and simple to use, and are appealing to increasing numbers of people. Greater development of digital health platforms and mobile applications that integrate with the kits is also increasing access and convenience. Market challenges include the demand for reliable and precise testing solutions, handling sensitive patient information, and navigating intricate regulatory environments. Additionally, cost and access to diverse populations are of concern to guarantee for market participants.

Innovation is driving the market. Companies are investing in research and development to create more sensitive and specific tests, develop advanced imaging technologies, and improve home testing kit accuracy. The integration of artificial intelligence and machine learning into fertility test platforms is also enhancing data analysis and personalized recommendations.

The increasing focus on tailored fertility treatment is propelling the development of customized testing solutions and treatment regimens. Adoption of telehealth and remote monitoring technology is also increasing access to fertility services and counseling. Increased awareness of male infertility and the development of advanced sperm testing technologies are also propelling market growth.

Lastly, the fertility testing market is a rapidly evolving and dynamic one. With increasing rates of infertility, technological advancements, and shifting social patterns, the market is likely to expand even more. Through overcoming obstacles, embracing innovation, and centering on patient-centered care, market participants can ensure that they lead towards improved reproductive health outcomes and enable individuals to achieve success in their family planning efforts.

Author's Bio:

Nilesh Shinde

Senior Market Research expert at The Insight Partners

[bobbyimarc]

Surrogacy Market Report 2024–2033: Industry Trends, Growth Drivers, and Forecast

The global surrogacy market is experiencing significant growth, driven by the increasing prevalence of infertility and the rising acceptance of surrogacy as a viable option for parenthood. In 2024, the market was valued at USD 194.0 million and is projected to reach USD 321.4 million by 2033, exhibiting a CAGR of 5.48% during 2025–2033. Factors such as the expansion of fertility tourism, affordable surrogacy options, and supportive governmental policies are key contributors to this upward trend.

Study Assumption Years:

Base Year: 2024

Historical Years: 2019–2024

Forecast Years: 2025–2033

Surrogacy Market Key Takeaways:

Market Size and Growth: The surrogacy market was valued at USD 194.0 million in 2024 and is expected to reach USD 321.4 million by 2033, growing at a CAGR of 5.48% during the forecast period.

Regional Performance: The market is witnessing robust growth in regions with favorable legal frameworks and advanced healthcare infrastructures, attracting both domestic and international intended parents.

Market Segmentation: The market is segmented by type (gestational and traditional surrogacy), technology (IVF with ICSI, IVF without ICSI, intrauterine insemination), and service providers (hospitals, fertility clinics, others).

Key Trends: Advancements in assisted reproductive technologies (ART) and increasing societal acceptance of diverse family structures are propelling market growth.

Regulatory Impact: Supportive governmental policies and clear legal guidelines are enhancing the accessibility and appeal of surrogacy services globally.

Market Growth Factors:

Surge in the surrogacy market as infertility has risen worldwide. Some of the reasons for it are lifestyle changes, delay in child birth, and health issues. The ever-changing scenario has immensely increased the trend in couples who are facing nature’s challenge in terms of child birth. It is a clear remedy in these situations, as it is the most prominent one.

Assisted reproductive technologies (ART) have made surrogacy greatly affected by high geographical success rates; in particular, in vitro fertilization (IVF) markedly improved with intracytoplasmic sperm injection (ICSI) and applications of improved embryo transfer techniques have shown successful results. The great extent of its effect is substantial and notable in the enhancement of probability of the success of pregnancies. This is making parents intend for treatment from such medical interventions and widens the pool of candidates eligible for surrogacy, thereby improving the market as the parents seeking solutions are more and more likely to avail themselves.

Policies of the government and proper legal framework sought positive outcomes in the growth of the surrogacy market. More and more, countries are getting themselves equipped with clear regulations and considerate support systems, thereby making it more available and ethically fine to due surrogacy. The norms are also drawing intended future parents both from domestic and international grounds level, which eventually leads to a high-ranking booming surrogacy industry. With this also, there have been some regions which are known for their low costing surrogacy options, and such regions have fostered fertility tourism, again boosting the market.

Request for a sample copy of this report : https://www.imarcgroup.com/surrogacy-market/requestsample

Market Segmentation:

By Type:

Gestational Surrogacy: The surrogate carries an embryo with no genetic relation to her, created using the intended parents’ or donors’ gametes.

Traditional Surrogacy: The surrogate is artificially inseminated with the intended father’s sperm, making her the genetic mother of the child.

By Technology:

IVF with ICSI: Involves injecting a single sperm directly into an egg to facilitate fertilization, commonly used in cases of male infertility.

IVF without ICSI: Standard in vitro fertilization where eggs and sperm are combined in a lab to allow natural fertilization.

Intrauterine Insemination (IUI): Sperm is placed directly into a woman’s uterus to increase the chance of fertilization.

By Service Provider:

Hospitals: Medical institutions offering comprehensive surrogacy services, including medical procedures and legal support.

Fertility Clinics: Specialized centers focusing on reproductive health and offering various ART services.

Others: Includes surrogacy agencies and independent practitioners providing related services.

Breakup by Region:

North America (United States, Canada)

Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America (Brazil, Mexico, Others)

Middle East and Africa

Regional Insights:

North America dominates the surrogacy market, attributed to its advanced healthcare infrastructure, favorable legal environment, and high awareness levels. The region’s supportive policies and availability of cutting-edge ART services attract numerous intended parents, both domestically and internationally.

Recent Developments & News:

The surrogacy market has seen notable advancements, including the integration of genetic screening technologies to enhance embryo selection and success rates. Additionally, there’s a growing trend of cross-border surrogacy arrangements, driven by varying legal frameworks and cost considerations. These developments reflect the dynamic nature of the surrogacy landscape, continually evolving to meet the needs of intended parents worldwide.

Key Players:

Bourn Hall Clinic

CARE Fertility

Circle Surrogacy & Egg Donation

Extraordinary Conceptions

Growing Generations LLC

Houston Fertility Center

IVIRMA Global

Max Healthcare

New Hope Fertility Center

Nova IVF

Ovation Fertility

Scanfert Clinic

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=5298&flag=C

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

[rainyducktiger]

In Vitro Fertilization (IVF) Services Market Consumer Behavior and Industry Shifts to 2033

In vitro fertilization (IVF) is a widely used assisted reproductive technology (ART) that has transformed fertility treatments globally. It involves the fertilization of an egg outside the body in a laboratory setting, followed by the implantation of the embryo into the uterus. The global IVF services market has experienced rapid growth due to rising infertility rates, increasing awareness, technological advancements, and evolving societal norms regarding parenthood. This article delves into the industry trends, market dynamics, growth factors, challenges, and forecasts for the IVF services market through 2032.

Market Overview

The global IVF services market is anticipated to witness significant expansion from 2024 to 2032. The increasing prevalence of infertility due to lifestyle changes, delayed pregnancies, and growing acceptance of IVF treatments are key contributors to this growth. The market encompasses various stakeholders, including fertility clinics, hospitals, research centers, and pharmaceutical companies specializing in reproductive medicine.

Download a Free Sample Report:- https://tinyurl.com/5dteckfx

Key Market Drivers

1. Rising Infertility Rates

Infertility is a growing concern worldwide, influenced by lifestyle factors such as stress, obesity, late marriages, and smoking. The increasing number of individuals facing fertility issues has spurred the demand for IVF services.

2. Technological Advancements in Assisted Reproductive Technologies

Innovations in IVF procedures, such as time-lapse imaging, preimplantation genetic testing (PGT), cryopreservation, and artificial intelligence (AI) in embryo selection, are improving success rates and boosting market growth.

3. Growing Awareness and Acceptance of IVF

Increased awareness about infertility treatments, changing societal attitudes, and supportive government policies have contributed to higher acceptance of IVF procedures, particularly in emerging economies.

4. Favorable Reimbursement Policies

Several governments and insurance providers are offering partial or full coverage for IVF treatments, reducing the financial burden on patients and driving market demand.

5. Rise in Medical Tourism

Countries like India, Thailand, Spain, and the Czech Republic have become popular destinations for affordable and high-quality IVF services, attracting patients from regions with expensive treatments.

Market Challenges

1. High Cost of Treatment

IVF procedures are expensive, making them inaccessible to many individuals, particularly in low-income countries. The cost includes consultation, medication, laboratory procedures, and multiple cycles if required.

2. Ethical and Legal Concerns

Religious and ethical issues regarding embryo selection, surrogacy, and genetic modifications pose challenges to the market. Additionally, varying regulations across countries impact the accessibility of IVF services.

3. Emotional and Physical Strain on Patients

IVF treatments involve multiple procedures, hormonal therapies, and emotional stress, which can deter some couples from undergoing the process.

Market Segmentation

The IVF services market can be segmented based on service type, end-user, and geography.

1. By Service Type

Fresh Donor IVF

Fresh Non-Donor IVF

Frozen Donor IVF

Frozen Non-Donor IVF

2. By End-User

Fertility Clinics

Hospitals

Cryobanks

Research Institutes

3. By Geography

North America: The U.S. dominates due to advanced healthcare infrastructure and insurance coverage for IVF.

Europe: Countries like the UK, Spain, and Germany lead in fertility treatments and research.

Asia-Pacific: Rapid market expansion due to rising infertility rates and affordable treatment options.

Latin America & Middle East: Increasing adoption of IVF services with improving medical facilities.

Future Trends

1. Integration of Artificial Intelligence

AI-driven algorithms are being used to select high-quality embryos, improving success rates and reducing failed cycles.

2. Genetic Screening and Customization

Advancements in preimplantation genetic testing (PGT) allow parents to screen embryos for genetic disorders, leading to healthier pregnancies.

3. Rise in Single Parenthood and LGBTQ+ Family Building

With changing societal norms, more single individuals and same-sex couples are opting for IVF and surrogacy services, expanding the market.

4. Nanotechnology in Embryo Development

Researchers are exploring nanotechnology to enhance embryo culture media, improving embryo viability and pregnancy success rates.

5. Expansion of Fertility Preservation Services

Egg freezing and sperm banking are becoming popular among individuals who wish to delay parenthood for personal or medical reasons.

Market Forecast (2024-2032)

The IVF services market is projected to grow at a CAGR of approximately XX% during the forecast period. North America and Europe are expected to maintain dominance due to high adoption rates and government support. Meanwhile, Asia-Pacific is likely to witness the fastest growth due to increasing fertility awareness, affordability, and medical tourism.

Key Players in the Market

Boston IVF

Merck KGaA

Vitrolife AB

CooperSurgical

FUJIFILM Irvine Scientific

Genea Limited

CARE Fertility

Monash IVF

Virtus Health

Thermo Fisher Scientific Inc

Cook Medical

EMD Serono Inc

OvaScience

IVI-RMA Global

Shady Grove Fertility

Reproductive Medicine Associates (RMA) Network

Pacific Fertility Center

The Fertility Partnership

Bloom IVF Group

Cloudnine Fertility

Conclusion

The IVF services market is set to experience robust growth driven by rising infertility rates, technological advancements, and increasing acceptance of fertility treatments. However, high costs, ethical concerns, and varying regulations pose challenges. Companies investing in AI, genetic screening, and fertility preservation are likely to gain a competitive edge. With evolving medical technologies and shifting societal norms, the market will continue to expand, offering hope to millions seeking parenthood.

For More Information About This Research Please Visit: https://www.uniprismmarketresearch.com/verticals/healthcare/in-vitro-fertilization-ivf-services

[chemanalystdata]

Progesterone Prices, News, Trend, Graph, Chart, Monitor and Forecast

 The global progesterone market has witnessed substantial growth in recent years, driven by increasing demand from the pharmaceutical and healthcare sectors. Progesterone, a crucial hormone in reproductive health, is widely used in hormone replacement therapy (HRT), infertility treatments, and gynecological disorders. The rising prevalence of conditions such as polycystic ovary syndrome (PCOS), endometriosis, and hormonal deficiencies has significantly increased the demand for progesterone-based medications. Additionally, advancements in assisted reproductive technologies (ART) and growing awareness about hormone-related health issues have further contributed to market expansion. The increasing use of progesterone in the production of contraceptive drugs, as well as in veterinary applications, is another factor boosting demand.

The progesterone price market is influenced by various factors, including raw material availability, manufacturing costs, and regulatory policies. The extraction of progesterone from plant-based sources such as diosgenin (found in wild yams and soybeans) and synthetic production processes have a significant impact on its pricing. Supply chain disruptions, environmental concerns, and geopolitical factors also play a crucial role in price fluctuations. The pharmaceutical industry's stringent regulatory requirements further affect production costs, as manufacturers must comply with Good Manufacturing Practices (GMP) and ensure the quality and efficacy of their products. The increasing research and development activities in bio-identical hormones and innovative drug formulations are expected to drive market growth while potentially stabilizing prices through technological advancements.

Get Real time Prices for Progesterone: https://www.chemanalyst.com/Pricing-data/progesterone-1648

The regional distribution of the progesterone market highlights varying price trends across different areas. North America and Europe remain dominant players due to their advanced healthcare infrastructure, high adoption rates of hormone therapies, and the presence of leading pharmaceutical companies. The United States, in particular, has a significant share of the market, driven by rising cases of infertility and menopause-related health concerns. In Europe, increasing awareness and government initiatives promoting women's health have contributed to market expansion. Meanwhile, the Asia-Pacific region is emerging as a lucrative market due to its growing pharmaceutical industry, increasing healthcare investments, and rising prevalence of gynecological disorders. Countries like China and India are witnessing a surge in demand due to improved access to healthcare services, expanding medical tourism, and increasing awareness regarding reproductive health. The Middle East and Africa, while still developing in terms of healthcare infrastructure, are gradually showing growth potential due to improving medical facilities and rising demand for hormone treatments.

Market competition plays a critical role in progesterone pricing. Key players in the industry, including Pfizer Inc., Merck & Co., Inc., Bayer AG, and Teva Pharmaceuticals, are actively involved in research, product development, and strategic partnerships to maintain a competitive edge. The presence of both branded and generic progesterone products affects pricing dynamics, with generic manufacturers often offering cost-effective alternatives that drive price competition. The increasing demand for natural and bio-identical progesterone formulations has further influenced pricing strategies, as consumers seek safer and more effective alternatives to synthetic hormone therapies.

The rising demand for progesterone has also led to increased investment in production technologies and supply chain improvements. Manufacturers are focusing on optimizing production efficiency and exploring alternative raw material sources to reduce costs and ensure consistent supply. The integration of artificial intelligence and automation in pharmaceutical manufacturing is expected to streamline production processes, enhance quality control, and contribute to cost reductions. Additionally, companies are investing in expanding their production facilities and entering new markets to capitalize on emerging opportunities.

Regulatory policies and government interventions play a significant role in shaping the progesterone market. Strict regulations regarding drug approval, safety, and efficacy impact the availability and pricing of progesterone-based products. The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regulatory bodies impose stringent guidelines on the manufacturing and distribution of hormone-based drugs, which can influence market dynamics. In some regions, government initiatives promoting women's health and reproductive care have led to increased funding and accessibility to hormone therapies, positively impacting market growth.

Despite the positive outlook, the progesterone market faces challenges, including supply chain disruptions, fluctuating raw material costs, and potential side effects associated with hormone therapy. Supply chain issues, exacerbated by global events such as the COVID-19 pandemic, have led to temporary shortages and price fluctuations. Additionally, concerns regarding the long-term effects of hormone therapy, including an increased risk of cardiovascular diseases and cancer, have led to cautious adoption among some patient groups. Addressing these concerns through continued research, improved formulations, and better patient education will be crucial for sustaining market growth.

The future of the progesterone market looks promising, with ongoing research into innovative drug delivery methods, including transdermal patches, subcutaneous implants, and sustained-release formulations. These advancements aim to enhance patient compliance, reduce side effects, and improve treatment efficacy. The increasing acceptance of personalized medicine and precision healthcare is also expected to drive demand for customized hormone therapies tailored to individual patient needs. Additionally, the growing interest in plant-based and bio-identical progesterone alternatives is likely to shape market trends in the coming years.

In conclusion, the progesterone price market is influenced by a complex interplay of factors, including raw material availability, regulatory policies, market competition, and technological advancements. With increasing demand from the pharmaceutical and healthcare sectors, coupled with growing awareness about reproductive health, the market is poised for steady growth. However, addressing challenges such as supply chain disruptions, regulatory hurdles, and safety concerns will be essential for ensuring sustainable expansion. As research and development efforts continue to drive innovation, the progesterone market is expected to witness significant transformations, ultimately benefiting patients and healthcare providers worldwide.

Get Real time Prices for Progesterone: https://www.chemanalyst.com/Pricing-data/progesterone-1648

Contact Us:

ChemAnalyst

GmbH - S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com

[deshpandeisha]

Market Overview of Electrical Hospital Beds: Trends and Growth Prospects

The global electrical hospital beds market size was USD 2.60 Billion in 2022 and is expected to register a rapid revenue CAGR of 7.3% during the forecast period. Rising number of surgical procedures, increasing admission of aged patients to support electrical hospital beds therapies, and technological advancements in making electrical beds are key factors driving market revenue growth.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/2808

Competitive Terrain:

The global Electrical Hospital Beds industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Medline Industries, Inc., Arjo, Hill-Rom Services Inc., PARAMOUNT BED CO., LTD., Stryker, Invacare Corporation, Malvestio Spa, Midmark India Pvt. Ltd., Gendron Inc., and LINET

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Electrical Hospital Beds market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Electrical Hospital Beds market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Electrical Hospital Beds market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/2808

Market Segmentations of the Electrical Hospital Beds Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Electrical Hospital Beds market on the basis of product, application, and region:

Segments Covered in this report are:

Type Outlook (Revenue, USD Billion; 2019-2032)

Semi-automatic electric bed

Fully automatic electric bed

Application Outlook (Revenue, USD Billion; 2019-2032)

General beds

Intensive care beds

Bariatric beds

Birthing beds

Others

End-Users Outlook (Revenue, USD Billion; 2019-2032)

Hospitals

Dentistry

Reproductive care centers

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/electrical-hospital-beds-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2808

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market

Latest Report:  Ceramic Tiles Market | Life Science Analytics Market

[healthcarediagnosticmarket]

Progesterone Market Key Player Analysis: Growth Insights and Forecasts , Business Strategies, Challenges and Future Demand 2033

Global Progesterone Market Growth and Trends – Straits Research

Straits Research is pleased to present its comprehensive report on the global Progesterone Market, detailing market size, growth projections, trends, and key insights. With a projected CAGR of 12.3% from 2024 to 2032, the market is set to experience substantial growth, increasing from USD 1.50 billion in 2024 to USD 4.14 billion by 2032.

Market Definition:

Progesterone is a vital hormone, predominantly used in hormonal therapies. It plays a key role in regulating the menstrual cycle, supporting pregnancy, and managing conditions like dysfunctional uterine bleeding and endometrial cancer. There is a significant demand for progesterone in various medical treatments, driving its growing market share.

The global progesterone market is expected to grow rapidly due to increasing adoption of progesterone-based therapies for conditions such as menstrual irregularities, hormonal imbalances, contraception, and cancer therapies. This surge is also bolstered by the growing awareness of women's health and rising healthcare spending worldwide.

Market Size and Forecast

In 2023, the global progesterone market was valued at USD 1.34 billion. As the demand for progesterone-based treatments continues to rise, the market is projected to expand from USD 1.50 billion in 2024 to an estimated USD 4.14 billion by 2032. This growth will be driven by increasing healthcare expenditures, evolving consumer preferences for hormonal therapies, and expanding awareness around reproductive health.

Key Trends in the Progesterone Market:

Rise in Hormonal Therapy Awareness: The increasing awareness about the benefits of hormonal therapies, especially progesterone in regulating menstrual cycles and treating various gynecological disorders, is propelling the market's growth.

Technological Advancements in Drug Delivery Systems: Advances in the development of new drug delivery systems, such as injectable and oral progesterone formulations, are improving treatment outcomes and ensuring better patient compliance.

Growing Use in Contraceptive Treatments: The application of progesterone in contraception, particularly in the form of intrauterine devices (IUDs) and oral contraceptives, is significantly boosting market growth.

Growth Factors:

The progesterone market is witnessing substantial growth due to several driving factors:

Increasing Incidence of Hormonal Disorders: The rise in conditions like irregular menstrual cycles, menopause, and polycystic ovary syndrome (PCOS) is fueling the demand for progesterone-based treatments.

Expanding Healthcare Infrastructure in Emerging Economies: Improved access to healthcare, especially in regions like Asia-Pacific and Latin America, is driving the demand for progesterone therapies.

Aging Population and Increasing Healthcare Investments: With an aging global population and rising healthcare investments, the demand for progesterone, particularly in managing conditions related to reproductive health and endometrial cancer, is expected to rise.

Key Market Opportunities:

Unmet Needs in Fertility Treatments: There is a significant opportunity for the progesterone market to cater to the growing demand for fertility treatments, particularly in assisted reproductive technologies (ART) such as IVF.

Increasing Adoption of Bio-Similars: The adoption of bio-similar progesterone therapies, which offer cost-effective alternatives to branded treatments, presents significant growth opportunities for market players.

Research & Development in Personalized Medicine: Advancements in personalized medicine, tailored to specific hormonal needs, create opportunities for developing targeted progesterone therapies, thereby driving market expansion.

Market Segmentation:

The global progesterone market can be segmented as follows:

By Type:

<ol> <li>Natural Progesterone</li> <li>Synthetic Progesterone</li> </ol>

By Modes of Delivery Source:

<ol> <li>Injectable</li> <li>Suspended Form</li> <li>Oral</li> <li>Intravaginal</li> <li>Others</li> </ol>

By Application:

<ol> <li>Regulation of the Menstrual Cycle</li> <li>Dysfunctional Uterine Bleeding</li> <li>Endometrial Cancer</li> <li>Contraception</li> <li>Others</li> </ol>

For more detailed market segmentation, access the full report at this link.

Key Players in the Progesterone Market:

<ol> <li>Sofgen Pharmaceuticals</li> <li>Pfizer Inc.</li> <li>Cipla Limited</li> <li>Lupin</li> <li>Aquatic Remedies Pvt. Ltd.</li> <li>Wuhan Honor Bio-Pharm Co., Ltd</li> <li>Shanghai Yijing Industrial Co., Ltd.</li> <li>Estrellas Life Sciences Private Limited</li> <li>Intas Pharmaceuticals Ltd.</li> <li>AdvaCare Pharma</li> </ol>

Regional Insights:

Dominated Region: North America holds the largest share of the global progesterone market. The region's advanced healthcare infrastructure, higher demand for hormonal therapies, and extensive research and development activities have contributed to its dominance.

Fastest Growing Region: Europe is expected to be the fastest-growing market for progesterone due to an increasing awareness of reproductive health, an aging population, and the rising adoption of hormone-based treatments.

For More Information or Queries

To request more information, ask for customizations, or inquire about purchasing the full report, visit: this link.

Straits Research continues to provide insightful, data-driven research reports designed to help industry players, investors, and stakeholders make informed decisions. With our comprehensive analysis and projections, stakeholders can plan for future market developments and capitalize on emerging opportunities in the progesterone market.

About Straits Research:

Straits Research is a leading market research and consulting firm that provides in-depth analysis of global industries, delivering insights into market trends, forecasts, and strategic growth opportunities. With a robust team of experts and comprehensive data-driven reports, Straits Research helps clients gain a competitive edge and drive business growth.

Contact Us

Email: sales@straitsresearch.com

Address: 825 3rd Avenue, New York, NY, USA, 10022

Tel: UK: +44 203 695 0070, USA: +1 646 905 0080

[memphasys]

We’re excited to share that our Felix™ System is nearing the completion of its clinical trial in Australia, with 95% of patient recruitment already completed. If current recruitment rates are maintained, the study is expected to conclude by the end of this calendar year. This will provide us with essential data to support our regulatory submissions and market expansion efforts. As demand for innovative fertility solutions continues to rise, Memphasys is positioning itself at the forefront of the global assisted reproductive technology (ART) market.

Read more : https://www.memphasys.com/memphasys-targets-global-fertility-market-as-clinical-trial-nears-completion/

[marketanalysisdata]

Biopreservation Market Revenue, Share and Growth Rate to 2030

The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.

Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market

Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.

In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.

However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.

Application Segmentation Insights:

In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.

The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.